# First Commonwealth Financial Corp: financial statements, quarterly

FCF · NYSE · CIK 712537 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcf.md) · [Financials](/companies/fcf/financials.md) · [Filings](/companies/fcf/filings.md) · [Insiders](/companies/fcf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fcf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [42.1](/filings/0000712537-24-000121.md) | [48.5 d](/filings/0000712537-26-000013.md) | [53.2](/filings/0000712537-25-000088.md) | [55.7](/filings/0000712537-25-000107.md) | [57.8](/filings/0000712537-25-000129.md) | [54.9 d](/filings/0000712537-26-000013.md) | [51.6](/filings/0000712537-26-000022.md) | [52.7](/filings/0000712537-26-000030.md) | [51.6](/filings/0000712537-25-000129.md) | [50.7 d](/filings/0000712537-26-000013.md) | [48.2](/filings/0000712537-26-000022.md) | [46.9](/filings/0000712537-26-000030.md) |
| Income tax | $m | [10.1](/filings/0000712537-24-000121.md) | [11.9 d](/filings/0000712537-26-000013.md) | [8.9](/filings/0000712537-25-000088.md) | [9.5](/filings/0000712537-25-000107.md) | [8.4](/filings/0000712537-25-000129.md) | [8.8 d](/filings/0000712537-26-000013.md) | [8.3](/filings/0000712537-26-000022.md) | [8.7](/filings/0000712537-26-000030.md) | [10.5](/filings/0000712537-25-000129.md) | [11.6 d](/filings/0000712537-26-000013.md) | [9.7](/filings/0000712537-26-000022.md) | [11.7](/filings/0000712537-26-000030.md) |
| Net income | $m | [39.2](/filings/0000712537-24-000121.md) | [44.8 d](/filings/0000712537-26-000013.md) | [37.5](/filings/0000712537-25-000088.md) | [37.1](/filings/0000712537-25-000107.md) | [32.1](/filings/0000712537-25-000129.md) | [35.8 d](/filings/0000712537-26-000013.md) | [32.7](/filings/0000712537-26-000022.md) | [33.4](/filings/0000712537-26-000030.md) | [41.3](/filings/0000712537-25-000129.md) | [44.9 d](/filings/0000712537-26-000013.md) | [37.5](/filings/0000712537-26-000022.md) | [44.6](/filings/0000712537-26-000030.md) |
| Diluted EPS | $ per share | [0.38](/filings/0000712537-24-000121.md) | not reported | [0.37](/filings/0000712537-25-000088.md) | [0.36](/filings/0000712537-25-000107.md) | [0.31](/filings/0000712537-25-000129.md) | not reported | [0.32](/filings/0000712537-26-000022.md) | [0.32](/filings/0000712537-26-000030.md) | [0.39](/filings/0000712537-25-000129.md) | not reported | [0.37](/filings/0000712537-26-000022.md) | [0.44](/filings/0000712537-26-000030.md) |
| Basic EPS | $ per share | [0.38](/filings/0000712537-24-000121.md) | not reported | [0.37](/filings/0000712537-25-000088.md) | [0.36](/filings/0000712537-25-000107.md) | [0.31](/filings/0000712537-25-000129.md) | not reported | [0.32](/filings/0000712537-26-000022.md) | [0.32](/filings/0000712537-26-000030.md) | [0.40](/filings/0000712537-25-000129.md) | not reported | [0.37](/filings/0000712537-26-000022.md) | [0.44](/filings/0000712537-26-000030.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [11.4](/filings/0000712537-23-000112.md) | [11.5](/filings/0000712537-25-000061.md) | [11.7](/filings/0000712537-24-000087.md) | [11.6](/filings/0000712537-24-000101.md) | [12.0](/filings/0000712537-24-000121.md) | [11.6](/filings/0000712537-26-000013.md) | [11.8](/filings/0000712537-25-000088.md) | [12.2](/filings/0000712537-25-000107.md) | [12.3](/filings/0000712537-25-000129.md) | [12.3](/filings/0000712537-26-000030.md) | [12.3](/filings/0000712537-26-000022.md) | [12.2](/filings/0000712537-26-000030.md) |
| Total liabilities | $bn | [10.2](/filings/0000712537-23-000112.md) | [10.1](/filings/0000712537-25-000061.md) | [10.4](/filings/0000712537-24-000087.md) | [10.3](/filings/0000712537-24-000101.md) | [10.6](/filings/0000712537-24-000121.md) | [10.2](/filings/0000712537-26-000013.md) | [10.3](/filings/0000712537-25-000088.md) | [10.7](/filings/0000712537-25-000107.md) | [10.8](/filings/0000712537-25-000129.md) | [10.8](/filings/0000712537-26-000030.md) | [10.7](/filings/0000712537-26-000022.md) | [10.6](/filings/0000712537-26-000030.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [0.5](/filings/0000712537-23-000112.md) | [0.6](/filings/0000712537-26-000013.md) | [0.5](/filings/0000712537-24-000087.md) | [0.5](/filings/0000712537-24-000101.md) | [0.5](/filings/0000712537-24-000121.md) | [0.1](/filings/0000712537-26-000013.md) | [0.1](/filings/0000712537-25-000088.md) | [0.2](/filings/0000712537-25-000107.md) | [0.1](/filings/0000712537-25-000129.md) | [0.1](/filings/0000712537-26-000030.md) | [0.0](/filings/0000712537-26-000022.md) | [0.1](/filings/0000712537-26-000030.md) |
| Shareholders' equity | $bn | [1.2](/filings/0000712537-24-000121.md) | [1.3](/filings/0000712537-26-000013.md) | [1.3](/filings/0000712537-25-000088.md) | [1.4](/filings/0000712537-25-000107.md) | [1.4](/filings/0000712537-25-000129.md) | [1.4](/filings/0000712537-26-000030.md) | [1.4](/filings/0000712537-26-000030.md) | [1.5](/filings/0000712537-26-000030.md) | [1.5](/filings/0000712537-25-000129.md) | [1.6](/filings/0000712537-26-000030.md) | [1.6](/filings/0000712537-26-000030.md) | [1.6](/filings/0000712537-26-000030.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [20.4 d](/filings/0000712537-24-000121.md) | [44.0 d](/filings/0000712537-26-000013.md) | [39.6](/filings/0000712537-25-000088.md) | [22.7 d](/filings/0000712537-25-000107.md) | [53.6 d](/filings/0000712537-25-000129.md) | [13.5 d](/filings/0000712537-26-000013.md) | [55.9](/filings/0000712537-26-000022.md) | [30.4 d](/filings/0000712537-26-000030.md) | [49.5 d](/filings/0000712537-25-000129.md) | [51.8 d](/filings/0000712537-26-000013.md) | [86.8](/filings/0000712537-26-000022.md) | [3.6 d](/filings/0000712537-26-000030.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [12.8 d](/filings/0000712537-24-000121.md) | [12.8 d](/filings/0000712537-26-000013.md) | [12.8](/filings/0000712537-25-000088.md) | [13.3 d](/filings/0000712537-25-000107.md) | [13.3 d](/filings/0000712537-25-000129.md) | [13.2 d](/filings/0000712537-26-000013.md) | [13.2](/filings/0000712537-26-000022.md) | [14.2 d](/filings/0000712537-26-000030.md) | [14.1 d](/filings/0000712537-25-000129.md) | [14.0 d](/filings/0000712537-26-000013.md) | [13.8](/filings/0000712537-26-000022.md) | [14.2 d](/filings/0000712537-26-000030.md) |
| Share repurchases | $m | [3.2 d](/filings/0000712537-24-000121.md) | [0.9 d](/filings/0000712537-26-000013.md) | [1.8](/filings/0000712537-25-000088.md) | [0.3 d](/filings/0000712537-25-000107.md) | [2.5 d](/filings/0000712537-25-000129.md) | [8.1 d](/filings/0000712537-26-000013.md) | [1.8](/filings/0000712537-26-000022.md) | [0.5 d](/filings/0000712537-26-000030.md) | [10.6 d](/filings/0000712537-25-000129.md) | [22.8 d](/filings/0000712537-26-000013.md) | [24.8](/filings/0000712537-26-000022.md) | [12.1 d](/filings/0000712537-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [93.5](/filings/0000712537-23-000112.md) | [99.8](/filings/0000712537-24-000087.md) | [103](/filings/0000712537-24-000101.md) | [102](/filings/0000712537-24-000121.md) | [102](/filings/0000712537-25-000088.md) | [102](/filings/0000712537-25-000107.md) | [102](/filings/0000712537-25-000129.md) | [102](/filings/0000712537-26-000022.md) | [104](/filings/0000712537-26-000030.md) | [105](/filings/0000712537-25-000129.md) | [102](/filings/0000712537-26-000022.md) | [102](/filings/0000712537-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 101,055,925 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0000712537-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.